S
Stoke Therapeutics
STOK
14.720
USD
-0.2
(-1.34%)
مغلق
حجم التداول
9,335
الربح لكل سهم
0
العائد الربحي
0
P/E
-6
حجم السوق
660,150,752
العنوان: Stoke Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Stoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregulating protein expression with RNA-based medicines. Using its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, it is developing antisense oligonucleotides (ASOs) to selectively restore protein levels. Its first compound, STK-001, is in clinical testing for the treatment of Dravet syndrome, a severe and progressive genetic epilepsy. The company primarily operates in the U.S.